DT
LEGN icon

Diversified Trust’s Legend Biotech LEGN Stock Holding History

Diversified Trust’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-41,051
Closed -$1.34M – 1075
2025
Q3 		$1.34M Sell
41,051
-4,720
-10% -$174K 0.03% 345
2025
Q2 		$1.62M Sell
45,771
-380
-0.8% -$12.3K 0.04% 276
2025
Q1 		$1.57M Buy
46,151
+863
+2% +$30.9K 0.04% 253
2024
Q4 		$1.47M Buy
45,288
+9,784
+28% +$405K 0.04% 287
2024
Q3 		$1.73M Buy
+35,504
New +$1.89M 0.04% 254

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Diversified Trust's LEGN Position: Q4 2025 in Review

Diversified Trust sold out of Legend Biotech (LEGN) in Q4 2025, closing a stake of 41,051 shares — an estimated $1.34M sold.

Diversified Trust first reported a position in LEGN in Q3 2024 and held it in 5 quarters. The position peaked at $1.73M in Q3 2024. 200 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

  • Diversified Trust reported no remaining Legend Biotech position as of Q4 2025 after selling out during the quarter.
  • Diversified Trust sold 41,051 Legend Biotech shares in Q4 2025, an estimated $1.34M.
  • Diversified Trust first reported a position in Legend Biotech in Q3 2024 and held it in 5 quarters.
  • Diversified Trust's Legend Biotech position peaked at $1.73M in Q3 2024.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on Diversified Trust's 13F filing for Q4 2025, filed 9 Jan 2026.